Latest week
10 Jul 2026
Close
225.800003
Fair value
150.141483
Next-week expectancy
Undecided 46.05%
Sharemaestro

JNJ Chart Pack

Johnson & Johnson

Exchange
VIE
Latest week
10 Jul 2026
Close
225.800003
Fair value
150.141483
Next-week expectancy
Undecided 46.05%
Generated
17 Jul 2026 22:26
Sector
Healthcare
Industry
Drug Manufacturers - General

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, JNJ rose 16.89%, moving from 193.17 to 225.80. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 2.94 and has improved across the 12-week window. Market Dynamics is 0.52 on the latest week. Next-week expectancy is undecided at 46.05% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
225.80
12-Week Change
16.89%
Trend Signal
Active
Next-Week Expectancy
Undecided 46.05%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
2.94
Market Dynamics
0.52

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
225.80
12-Week Change
16.89%
Trend Signal
Active
Next-Week Expectancy
Undecided 46.05%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
2.94
Market Dynamics
0.52

Over the latest 12 completed weeks ending 2026-07-10, JNJ rose 16.89%, moving from 193.17 to 225.80. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 2.94 and has improved across the 12-week window. Market Dynamics is 0.52 on the latest week. Next-week expectancy is undecided at 46.05% based on similar historical setup states.

Industry Peers

Austria equities in Drug Manufacturers - General

Stock Exchange Week Open High Low Close Change
REC Recordati Industria Chimica e Farmaceutica S.p.A. VIE 10 Jul 2026 51.45 51.55 51.30 51.35 -0.19%
GILD Gilead Sciences, Inc. VIE 10 Jul 2026 115.30 120.24 112.12 114.86 -0.38%
PFE Pfizer Inc. VIE 10 Jul 2026 21.29 21.36 20.73 21.20 -0.40%
ROGP ROCHE HOLDING AG PS VIE 10 Jul 2026 368.00 369.00 360.00 365.00 -0.82%
SANO Sanofi VIE 10 Jul 2026 76.96 77.16 74.48 76.09 -1.13%
BMYS Bristol-Myers Squibb Company VIE 10 Jul 2026 50.79 50.89 49.54 50.17 -1.22%
NNO2 Novo Nordisk A/S VIE 10 Jul 2026 43.86 44.47 42.44 43.21 -1.49%
ROGH Roche Holding AG VIE 10 Jul 2026 377.20 377.20 366.40 369.60 -2.01%
GRF Grifols, S.A. VIE 10 Jul 2026 9.12 9.12 8.90 8.92 -2.13%
LLYC Eli Lilly and Company VIE 10 Jul 2026 1064.20 1085.40 1037.60 1037.60 -2.50%
AMGN Amgen Inc. VIE 10 Jul 2026 326.70 326.95 317.60 318.25 -2.59%
MRK Merck & Co., Inc. VIE 10 Jul 2026 113.36 114.72 108.48 108.48 -4.30%
ABBV AbbVie Inc. VIE 10 Jul 2026 227.70 228.00 215.60 215.60 -5.31%
BAYN Bayer Aktiengesellschaft VIE 10 Jul 2026 53.64 53.76 49.49 50.18 -6.45%
COPN Cosmo N.V. VIE 10 Jul 2026 76.40 76.40 69.50 69.50 -9.03%
BIIB Biogen Inc. VIE 10 Jul 2026 190.60 190.96 172.66 172.66 -9.41%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.